Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Significance: The incidence of cardiovascular events (CVEs) increases with age, representing the main cause of death in an elderly population. Aging is associated with overproduction of reactive oxygen species (ROS), which may affect clotting and platelet activation, and impair endothelial function, thus predisposing elderly patients to thrombotic complications. Recent Advances: There is increasing evidence to suggest that aging is associated with an imbalance between oxidative stress and antioxidant status. Thus, upregulation of ROS-producing enzymes such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and myeloperoxidase, along with downregulation of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase, occurs during aging. This imbalance may predispose to thrombosis by enhancing platelet and clotting activation and eliciting endothelial dysfunction. Recently, gut-derived products, such as trimethylamine N-oxide (TMAO) and lipopolysaccharide, are emerging as novel atherosclerotic risk factors, and gut microbiota composition has been shown to change by aging, and may concur with the increased cardiovascular risk in the elderly. Critical Issues: Antioxidant treatment is ineffective in patients at risk or with cardiovascular disease. Further, anti-thrombotic treatment seems to work less in the elderly population. Future Directions: Interventional trials with antioxidants targeting enzymes implicated in aging-related atherothrombosis are warranted to explore whether modulation of redox status is effective in lowering CVEs in the elderly. Antioxid. Redox Signal. 27, 1083–1124. I. Introduction II. Oxidative Stress and Aging III. Atherothrombosis in Elderly: Clinical Studies A. Hypertension B. Diabetes mellitus C. Metabolic syndrome D. Atrial fibrillation E. Peripheral artery disease F. Interaction between cardiovascular risk factors in the elderly IV. Gut Microbiota and Atherothrombosis V. Atherosclerosis and Oxidative Stress in Animals and Humans VI. Pro-Oxidant Pathways A. Myeloperoxidase B. Lipoxygenases C. NADPH oxidase VII. Oxidative Products A. F2-isoprostanes B. Oxidized LDL VIII. Atherosclerosis and Antioxidant Status A. Antioxidant enzymes 1. NO synthase 2. Superoxide dismutase 3. Glutathione peroxidase 4. Paraoxonase 5. Heme-oxygenase B. Direct antioxidants 1. Glutathione 2. Vitamin E 3. Vitamin C C. Indirect antioxidants 1. Hydrogen sulfide 2. Polyphenols IX. Clotting Activation X. Platelet Activation XI. Endothelial Dysfunction XII. Antiplatelet and Anticoagulant Treatment XIII. Observational and Interventional Trials with Antioxidants in Humans XIV. Future Perspectives and Conclusions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257 · cited 22×
“Of note, during a follow-up of * 5 years, patients with elevated TxB 2 experienced more CVEs compared with those with lower TxB 2 .”
InfluentialRetractedTicagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117 · cited 1×
“The PLATO study (391) included 18,624 patients with ACS without ST segment elevation, to compare the efficacy of ticagrelor versus clopidogrel during a follow-up of 30 days.”
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
The World report on ageing and health: a policy framework for healthy ageing
Beard, J. R., Officer, A., de Carvalho, I. A., Sadana, R., Pot, A. M., Michel, J.-P., Lloyd-Sherlock, P., Epping-Jordan, J. E., Peeters, G. M. E. E. (., Mahanani, W. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00516-4 · Cited by 3,287
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · cited 1×
“In contrast with this hypothesis, a recent work showed that clonal hematopoiesis of indeterminate potential (CHIP), which is a common aging-related phenomenon characterized by the presence of an expanded somatic blood-cell clone in people without hematologic disease, which may lead to an increase in circulating myeloi…”
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513 · cited 1×
“Clotting system activation and endothelial dysfunction are other important mechanisms implicated in the occurrence of CVD, as they represent a backbone for both artery and venous thrombosis (76).”
Cited by
The Impact of Oxidative Stress in Human Pathology: Focus on Gastrointestinal Disorders
Vona, R., Pallotta, L., Cappelletti, M., Severi, C., & Matarrese, P. (2021) · Antioxidants · doi:10.3390/antiox10020201 · Cited by 431
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 374
Self-citationScioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
“Some animal studies showed that a genetic deficiency of Nox4 was associated with endothelial dysfunction and increased atherosclerosis burden [68].”
BackgroundInfluentialOxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
Loffredo, L., Ettorre, E., Zicari, A. M., Inghilleri, M., Nocella, C., Perri, L., Spalice, A., Fossati, C., De Lucia, M. C., Pigozzi, F., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8630275 · Cited by 100
Self-citation
Metadata
- Authors
- Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2017-11-10
- Volume
- 27
- Issue
- 14
- Pages
- 1083-1124
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2747811792
- Cited by
- 118
- References
- 67
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. https://app.cochat.ai/papers/10.1089/ars.2016.6963
- The paper
- Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017). Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2016.6963
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.